Léa Hoisnard
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Dermatology and Skin Diseases
Papers in
-
- Meningioma and schwannoma management 5
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Biosimilars and Bioanalytical Methods 3
- Co-authors
- É. Sbidian (10 shared papers)Mahmoud Zureik (10 shared papers)Alain Weill (7 shared papers)Laura Pina Vegas (2 shared papers)Rosemary Dray‐Spira (2 shared papers)Pascal Claudepierre (2 shared papers)Lise Duranteau (4 shared papers)Sébastien Froelich (4 shared papers)
- Journals
- Scientific Reports (2 papers)Transplant International (2 papers)European Journal of Neurology (2 papers)RMD Open (2 papers)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- FranceSwitzerlandCanada
In The Last Decade
Léa Hoisnard
17 papers receiving 302 citations
Léa Hoisnard's Hit Papers
Peers
Comparison fields: 5 of 64
- Rheumatology 118
- Dermatology 33
- Hematology 41
- Immunology 76
- Endocrinology, Diabetes and Metabolism 50
Countries citing papers authored by Léa Hoisnard
This map shows the geographic impact of Léa Hoisnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Hoisnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Hoisnard more than expected).
Fields of papers citing papers by Léa Hoisnard
This network shows the impact of papers produced by Léa Hoisnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Hoisnard. The network helps show where Léa Hoisnard may publish in the future.
Co-authors
The 25 scholars most cited alongside Léa Hoisnard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database Hit paper breakdown → | 2022 | 99 |
| 2 | 2022 | 83 | |
| 3 | 2022 | 35 | |
| 4 | 2024 | 25 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 7 | |
| 8 | 2018 | 7 | |
| 9 | 2024 | 6 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 6 | |
| 12 | 2024 | 4 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2025 | 0 |
About Léa Hoisnard
Léa Hoisnard is a scholar working on Epidemiology, Immunology, Genetics, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 18 papers that have together received 305 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (5 papers), Pituitary Gland Disorders and Treatments (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Pharmaceutical studies and practices (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Drug-Induced Adverse Reactions (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Rheumatology (118 citations), Dermatology (33 citations), Hematology (41 citations), Immunology (76 citations) and Endocrinology, Diabetes and Metabolism (50 citations). Léa Hoisnard has collaborated with scholars based in France, Switzerland and Canada. Frequent co-authors include É. Sbidian, Mahmoud Zureik, Alain Weill, Laura Pina Vegas, Rosemary Dray‐Spira, Pascal Claudepierre, Lise Duranteau, Sébastien Froelich, Philippe Grimbert and Bénédicte Lebrun‐Vignes. Their work appears in journals such as Scientific Reports, Transplant International, European Journal of Neurology, RMD Open and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.